NSCLC (NON-SMALL CELL LUNG CARCINOMA)
Clinical trials for NSCLC (NON-SMALL CELL LUNG CARCINOMA) explained in plain language.
Never miss a new study
Get alerted when new NSCLC (NON-SMALL CELL LUNG CARCINOMA) trials appear
Sign up with your email to follow new studies for NSCLC (NON-SMALL CELL LUNG CARCINOMA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for lung cancer patients with brain-spread disease
Disease control Not yet recruitingThis phase 2 trial tests a combination of the drug zorifertinib plus chemotherapy delivered directly into the fluid around the brain and spine. It is for people with a specific type of lung cancer (NSCLC with EGFR mutation) whose cancer has spread to the lining of the brain and s…
Matched conditions: NSCLC (NON-SMALL CELL LUNG CARCINOMA)
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New combo therapy targets rare lung cancer mutation
Disease control Not yet recruitingThis study tests a new drug (firmonertinib) combined with radiation therapy for people with a specific type of stage III lung cancer that cannot be removed by surgery. The cancer must have a rare change in the EGFR gene. The goal is to see if the combination can delay cancer grow…
Matched conditions: NSCLC (NON-SMALL CELL LUNG CARCINOMA)
Phase: PHASE2 • Sponsor: Hunan Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC